IL17A and breast carcinoma: A study of the correlation between the IL-17A level and clinicopathological parameters in patients with breast cancer showed that the number of IL-17A-producing cells in breast cancer tissue is related to a higher histological grade and negative ER/PR status but shows no relationship with tumor stage, tumor size, lymph node status, HER2 status, or histological type (9).